Cohen Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.7M | Sell |
74,849
-2,000
| -3% | -$300K | 1.59% | 20 |
|
|
2026
Q1 | $11.7M | Buy |
76,849
+236
| +0.3% | +$36.2K | 1.82% | 16 |
|
|
2025
Q4 | $10.6M | Hold |
76,613
| – | – | 1.59% | 20 |
|
|
2025
Q3 | $9.82M | Sell |
76,613
-650
| -0.8% | -$79.3K | 1.53% | 22 |
|
|
2025
Q2 | $9.35M | Sell |
77,263
-1,640
| -2% | -$185K | 1.52% | 21 |
|
|
2025
Q1 | $8.8M | Hold |
78,903
| – | – | 1.51% | 21 |
|
|
2024
Q4 | $7.68M | Sell |
78,903
-1,175
| -1% | -$125K | 1.28% | 23 |
|
|
2024
Q3 | $9.21M | Hold |
80,078
| – | – | 1.49% | 23 |
|
|
2024
Q2 | $8.53M | Hold |
80,078
| – | – | 1.47% | 21 |
|
|
2024
Q1 | $7.75M | Hold |
80,078
| – | – | 1.37% | 23 |
|
|
2023
Q4 | $8.09M | Sell |
80,078
-70
| -0.1% | -$6.76K | 1.54% | 21 |
|
|
2023
Q3 | $8.16M | Hold |
80,148
| – | – | 1.67% | 19 |
|
|
2023
Q2 | $8.09M | Hold |
80,148
| – | – | 1.57% | 20 |
|
|
2023
Q1 | $7.37M | Sell |
80,148
-368
| -0.5% | -$32.1K | 1.49% | 20 |
|
|
2022
Q4 | $7.3M | Hold |
80,516
| – | – | 1.49% | 21 |
|
|
2022
Q3 | $6.12M | Sell |
80,516
-1,500
| -2% | -$124K | 1.35% | 22 |
|
|
2022
Q2 | $6.93M | Hold |
82,016
| – | – | 1.42% | 22 |
|
|
2022
Q1 | $7.2M | Hold |
82,016
| – | – | 1.26% | 22 |
|
|
2021
Q4 | $7.17M | Hold |
82,016
| – | – | 1.17% | 26 |
|
|
2021
Q3 | $6.71M | Hold |
82,016
| – | – | 1.17% | 26 |
|
|
2021
Q2 | $7.48M | Sell |
82,016
-10
| -0% | -$890 | 1.28% | 23 |
|
|
2021
Q1 | $7.01M | Hold |
82,026
| – | – | 1.29% | 25 |
|
|
2020
Q4 | $7.75M | Sell |
82,026
-1,627
| -2% | -$142K | 1.55% | 21 |
|
|
2020
Q3 | $7.27M | Hold |
83,653
| – | – | 1.64% | 19 |
|
|
2020
Q2 | $7.31M | Hold |
83,653
| – | – | 1.79% | 15 |
|
|
2020
Q1 | $6.9M | Buy |
83,653
+870
| +1% | +$77.6K | 2.03% | 12 |
|
|
2019
Q4 | $7.84M | Hold |
82,783
| – | – | 1.7% | 18 |
|
|
2019
Q3 | $7.19M | Hold |
82,783
| – | – | 1.65% | 18 |
|
|
2019
Q2 | $7.56M | Sell |
82,783
-9,770
| -11% | -$827K | 1.76% | 19 |
|
|
2019
Q1 | $7.97M | Hold |
92,553
| – | – | 1.92% | 16 |
|
|
2018
Q4 | $7.12M | Buy |
92,553
+491
| +0.5% | +$38.2K | 1.97% | 15 |
|
|
2018
Q3 | $7.11M | Sell |
92,062
-1,920
| -2% | -$142K | 1.6% | 19 |
|
|
2018
Q2 | $6.36M | Buy |
93,982
+413
| +0.4% | +$28.5K | 1.47% | 22 |
|
|
2018
Q1 | $6.4M | Hold |
93,569
| – | – | 1.5% | 20 |
|
|
2017
Q4 | $7.04M | Buy |
93,569
+447
| +0.5% | +$33.7K | 1.64% | 19 |
|
|
2017
Q3 | $7.16M | Sell |
93,122
-558
| -0.6% | -$42.1K | 1.74% | 19 |
|
|
2017
Q2 | $7.01M | Hold |
93,680
| – | – | 1.75% | 20 |
|
|
2017
Q1 | $6.23M | Hold |
93,680
| – | – | 1.58% | 21 |
|
|
2016
Q4 | $6.11M | Sell |
93,680
-1,144
| -1% | -$74.2K | 1.67% | 21 |
|
|
2016
Q3 | $6.71M | Sell |
94,824
-1,284
| -1% | -$93.6K | 1.88% | 18 |
|
|
2016
Q2 | $7.11M | Hold |
96,108
| – | – | 2.07% | 15 |
|
|
2016
Q1 | $7.41M | Hold |
96,108
| – | – | 2.24% | 11 |
|
|
2015
Q4 | $7.41M | Buy |
96,108
+168
| +0.2% | +$13.3K | 2.24% | 11 |
|
|
2015
Q3 | $7.9M | Hold |
95,940
| – | – | 2.37% | 10 |
|
|
2015
Q2 | $8.45M | Hold |
95,940
| – | – | 2.18% | 9 |
|
|
2015
Q1 | $8.48M | Sell |
95,940
-502
| -0.5% | -$44.5K | 2.16% | 8 |
|
|
2014
Q4 | $8.01M | Hold |
96,442
| – | – | 2.08% | 11 |
|
|
2014
Q3 | $8.13M | Hold |
96,442
| – | – | 2.17% | 9 |
|
|
2014
Q2 | $7.82M | Hold |
96,442
| – | – | 2.02% | 12 |
|
|
2014
Q1 | $7.35M | Hold |
96,442
| – | – | 1.98% | 12 |
|
|
2013
Q4 | $6.95M | Hold |
96,442
| – | – | 1.96% | 10 |
|
|
2013
Q3 | $6.63M | Sell |
96,442
-1,518
| -2% | -$100K | 2.04% | 11 |
|
|
2013
Q2 | $6.21M | Buy |
+97,960
| New | +$6.37M | 1.98% | 11 |
|
Other funds holding NVS
SI
CPC
KAS
Cohen Capital Management's NVS Position: Q2 2026 in Review
Cohen Capital Management reduced its Novartis (NVS) stake by 2.6% in Q2 2026, selling an estimated $300K and leaving 74,849 shares worth $11.7M. The position accounts for 1.59% of the portfolio, ranked #20.
Cohen Capital Management first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.7M in Q1 2026. 756 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Cohen Capital Management held 74,849 shares of Novartis worth $11.7M as of Q2 2026.
- Cohen Capital Management sold 2,000 Novartis shares in Q2 2026, an estimated $300K.
- Novartis made up 1.59% of Cohen Capital Management's portfolio in Q2 2026, its #20 holding.
- Cohen Capital Management first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Cohen Capital Management's Novartis position peaked at $11.7M in Q1 2026.
- 756 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Cohen Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.